Patient characteristics of 150 patients with DLBCL before ICE chemotherapy
Characteristic . | No. . | % . |
|---|---|---|
| Disease status | ||
| Primary refractory | 67 | 45 |
| Relapsed | 83 | 55 |
| Sex | ||
| Male | 96 | 64 |
| Female | 54 | 36 |
| Age, y | ||
| Median | 49 | |
| Range | 16-86 | |
| Age stratified | ||
| Younger than 60 y | 125 | 83 |
| 60 y or older | 25 | 17 |
| KPS | ||
| 80% or more | 84 | 56 |
| Less than 80% | 66 | 44 |
| LDH | ||
| Normal | 63 | 42 |
| Below normal | 87 | 58 |
| ENS | ||
| One site or less | 84 | 56 |
| More than 1 site | 66 | 44 |
| Stage | ||
| I/II | 33 | 22 |
| III/IV | 17 | 78 |
| Bone marrow | ||
| Uninvolved | 117 | 78 |
| Involved | 33 | 22 |
| sAAIPI | ||
| Low | 20 | 13 |
| Low-intermediate | 40 | 27 |
| High-intermediate | 55 | 37 |
| High | 35 | 23 |
Characteristic . | No. . | % . |
|---|---|---|
| Disease status | ||
| Primary refractory | 67 | 45 |
| Relapsed | 83 | 55 |
| Sex | ||
| Male | 96 | 64 |
| Female | 54 | 36 |
| Age, y | ||
| Median | 49 | |
| Range | 16-86 | |
| Age stratified | ||
| Younger than 60 y | 125 | 83 |
| 60 y or older | 25 | 17 |
| KPS | ||
| 80% or more | 84 | 56 |
| Less than 80% | 66 | 44 |
| LDH | ||
| Normal | 63 | 42 |
| Below normal | 87 | 58 |
| ENS | ||
| One site or less | 84 | 56 |
| More than 1 site | 66 | 44 |
| Stage | ||
| I/II | 33 | 22 |
| III/IV | 17 | 78 |
| Bone marrow | ||
| Uninvolved | 117 | 78 |
| Involved | 33 | 22 |
| sAAIPI | ||
| Low | 20 | 13 |
| Low-intermediate | 40 | 27 |
| High-intermediate | 55 | 37 |
| High | 35 | 23 |
Response to ICE-based second-line chemotherapy: